معرفی
Sophie Fletcher is a Clinical Professor at the University of Southampton, affiliated with University Hospital Southampton (UHS). She has served as the clinical lead for the Respiratory Department (2018-2020) and played a pivotal role during the COVID-19 pandemic, leading clinical teams and co-chairing the RECOVERY trial, which validated dexamethasone's efficacy. She is the final year module lead for medicine in Wessex and received the Brian Latherdale Teaching Award (2021). Dr. Fletcher led the NHS-recognized ILD service (2013–2018), established the WILD patient support group, and chairs Southampton's ILD Multidisciplinary Team meetings. Her research focuses on interstitial lung diseases, pulmonary fibrosis, and clinical trial innovation. She has participated in multinational trials and published in high-impact journals.
Education and Training:
- BA Medical Science Tripos, Queens’ College, Cambridge University (1995)
- BM BCh, Magdalen College, Oxford University (2001)
- Postgraduate Training: St Thomas’ Hospital London and The Royal Brompton (2004)
- Higher Specialist Training in Respiratory, General, and Intensive Care Medicine, Wessex Deanery (2012)
Research Interests: Interstitial lung diseases (ILD), pulmonary fibrosis, clinical trial design, automated diagnostic systems, and patient adherence to antifibrotic therapies. Her work emphasizes translational research, leveraging AI and registry data to improve diagnostic accuracy and treatment outcomes.
Awards and Recognition:
- Brian Latherdale Award for Teaching (2021)
Advising and Grants: Supervises clinical fellows and participates in multinational trials. Leads the RECOVERY trial and contributes to the Adaptive Multi-interventional Trial Platform for fibrotic ILDs. Collaborates with organizations like the British Lung Foundation and the University of Southampton’s Biomedical Research Unit.
Labs and Teams: Chairs the Southampton ILD Multidisciplinary Team and oversees international ILD clinical fellowships. Collaborates with global partners in clinical research and patient advocacy initiatives.